Compare KRRO & EPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KRRO | EPM |
|---|---|---|
| Founded | 2014 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 150.0M | 158.2M |
| IPO Year | 2019 | 1996 |
| Metric | KRRO | EPM |
|---|---|---|
| Price | $14.01 | $4.43 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 3 |
| Target Price | ★ $34.80 | $4.93 |
| AVG Volume (30 Days) | 227.5K | ★ 419.3K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 10.98% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | $6,392,000.00 | ★ $43,229,621.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $87.48 |
| Revenue Growth | ★ 181.46 | N/A |
| 52 Week Low | $5.20 | $3.19 |
| 52 Week High | $55.89 | $5.70 |
| Indicator | KRRO | EPM |
|---|---|---|
| Relative Strength Index (RSI) | 65.53 | 46.87 |
| Support Level | $13.80 | $4.38 |
| Resistance Level | $14.96 | $4.63 |
| Average True Range (ATR) | 0.88 | 0.16 |
| MACD | 0.20 | -0.04 |
| Stochastic Oscillator | 90.36 | 13.04 |
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.
Evolution Petroleum Corp is an independent energy company focused on owning and investing in onshore oil and natural gas properties across the United States. Its portfolio includes non-operated interests in various production fields such as CO2 enhanced oil recovery in Louisiana, secondary recovery production in Wyoming, and shale gas reservoirs in Texas and North Dakota. The company generates revenue from the production and sale of oil and natural gas, leveraging specialized technologies to extend reservoir life and enhance recoveries.